ArticleExperimental & molecular medicine2021

Novel KCNQ4 variants in different functional domains confer genotype- and mechanism-based therapeutics in patients with nonsyndromic hearing loss.

Sang-Yeon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.